Loading…
CAMP4 THERAPEUTICS CORPORATION is projected to rise to $3.73 by 2027, a +8% move from its current price of $3.45. CAMP is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $3.31 | $3.45 | $3.59 | -0.04% |
| Aug 4 | $3.26 | $3.45 | $3.65 | -0.08% |
| Aug 5 | $3.22 | $3.45 | $3.69 | -0.12% |
| Aug 6 | $3.18 | $3.44 | $3.73 | -0.16% |
| Aug 7 | $3.15 | $3.44 | $3.76 | -0.20% |
| Aug 8 | $3.12 | $3.44 | $3.79 | -0.24% |
| Aug 9 | $3.10 | $3.44 | $3.82 | -0.28% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.10 | $3.44 | $3.82 | -0.28% |
| Week 2 | $2.96 | $3.43 | $3.98 | -0.56% |
| Week 3 | $2.85 | $3.42 | $4.10 | -0.84% |
| Week 4 | $2.77 | $3.41 | $4.21 | -1.12% |
| Week 5 | $2.69 | $3.40 | $4.30 | -1.39% |
| Week 6 | $2.62 | $3.39 | $4.39 | -1.67% |
| Week 7 | $2.56 | $3.38 | $4.46 | -1.95% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CAMP4 Therapeutics Corporation is a healthcare company that discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate CMP-001 is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders, and CMP-002 is developed for SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc.
and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
The asset sits in the Healthcare category and is positioned as a clinical-stage biopharmaceutical company focused on genetic diseases. The description reflects its location and corporate history, including the name change and headquarters in Cambridge, MA.
CAMP4 Therapeutics Corporation (CAMP) is currently priced at $3.42 and sits with a market capitalization of $177.59M. It is ranked 3720 by market cap among peers.
The price outlook shows year-by-year forecasts with the 2026 average price near the current level at $3.42, and notable upside in subsequent years. By 2030 the forecast projects an average price of $5.12, and by 2050 an average price of $13.06, with corresponding max values of $8.48 and $30.03 respectively.
Forecasts also show a path of rising sentiment from Neutral toward Bullish in later years, with a cumulative return (ROI) reaching 281.8% by 2050. The early years exhibit neutral expectations around the current price, while later years reflect stronger upside potential.
A major floor 37.3% below — a decisive break under it would weaken the trend.
The nearest floor, 12.8% below — buyers have tended to step in here.
The nearest ceiling, 30.4% above — a clean break opens room to run.
A major ceiling 49.1% above — clearing it would confirm fresh momentum.
Key CAMP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CAMP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.41 | Buy | $3.40 | Buy |
| MA 10 | $3.28 | Buy | $3.45 | Buy |
| MA 20 | $3.76 | Sell | $3.64 | Sell |
| MA 50 | $4.04 | Sell | $3.95 | Sell |
| MA 100 | $4.31 | Sell | $4.13 | Sell |
| MA 200 | $4.41 | Sell | $4.19 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.40 | Neutral |
| Stoch RSI (14) | 55.43 | Neutral |
| CCI (20) | -42.64 | Neutral |
| Williams %R (14) | -69.44 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -18.05 | Sell |
| Bollinger %B (20,2) | 0.35 | Neutral |
| Stochastic %K (14) | 30.56 | Neutral |
| TRIX (15) | -0.78 | Sell |
| Awesome (5,34) | -0.53 | Sell |
| Ultimate (7,14,28) | 53.21 | Neutral |
| Momentum (10) | -0.26 | Sell |
| Aroon Osc (25) | -32.00 | Sell |
| Hull MA (9) | 3.47 | Sell |
| ADX (14) | 18.66 | Neutral |
| ATR (14) | 0.15 | Info |
The 30-day technical picture is Bearish at the moment.
RSI14 is 40, with a 50-day moving average of $4.14 and a 200-day moving average of $4.42. Immediate support sits at $3.01 and resistance at $4.50.
The 30-day price range spans from $2.52 to $4.64, and annualized volatility is reported as 90.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.01 | $3.45 | $4.48 | 0% | Neutral | |
| $2.85 | $3.73 | $5.22 | +8% | Neutral | |
| $3.04 | $4.16 | $6.12 | +20% | Bullish | |
| $3.31 | $4.68 | $7.17 | +36% | Bullish | |
| $3.57 | $5.22 | $8.27 | +51% | Bullish | |
| $3.26 | $4.91 | $8.00 | +42% | Bullish | |
| $3.05 | $4.72 | $7.89 | +37% | Bullish | |
| $3.02 | $4.80 | $8.21 | +39% | Bullish | |
| $2.93 | $4.77 | $8.32 | +38% | Bullish | |
| $3.86 | $6.45 | $11.48 | +87% | Bullish | |
| $3.37 | $6.30 | $12.13 | +82% | Bullish | |
| $6.28 | $13.94 | $30.08 | +304% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.01 | $3.45 | $4.16 | +0.00% |
| September 2026 | $2.89 | $3.47 | $4.30 | +0.50% |
| October 2026 | $2.75 | $3.33 | $4.19 | -4.07% |
| November 2026 | $2.67 | $3.26 | $4.16 | -2.07% |
| December 2026 | $2.82 | $3.47 | $4.48 | +6.55% |
Click any year to see its month-by-month CAMP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
CAMP4 THERAPEUTICS CORPORATION's 2026 outlook centres on $3.45, within a $3.01 to $4.48 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, CAMP could reach as high as $5.22, with a base case around $3.73 and support toward $2.85 — roughly +8% from $3.45. A consolidation phase looks the most probable path here.
Expect CAMP to range from $3.04 to $6.12 through 2028. The $4.16 average target implies a +20% move from current prices. That is up +11% on the projected 2027 average. Momentum favours further upside here.
The CAMP price prediction for 2029 points to an average of $4.68 (low $3.31, high $7.17) — a potential gain of +36% on today's $3.45. Buyers look set to stay in control over this stretch.
In 2030, CAMP is projected to trade between $3.57 and $8.27, averaging $5.22 — a potential gain of +51% from today's $3.45. That is up +12% on the projected 2029 average. Momentum favours further upside here.
CAMP4 THERAPEUTICS CORPORATION's 2031 outlook centres on $4.91, within a $3.26 to $8.00 range. That is -6% versus the projected 2030 average. That marks a +42% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, CAMP could reach as high as $7.89, with a base case around $4.72 and support toward $3.05 — roughly +37% from $3.45. Momentum favours further upside here.
Expect CAMP to range from $3.02 to $8.21 through 2033. The $4.80 average target implies a +39% move from current prices. That is up +2% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The CAMP price prediction for 2034 points to an average of $4.77 (low $2.93, high $8.32) — a potential gain of +38% on today's $3.45. Momentum favours further upside here.
In 2035, CAMP is projected to trade between $3.86 and $11.48, averaging $6.45 — a potential gain of +87% from today's $3.45. That is up +35% on the projected 2034 average. Buyers look set to stay in control over this stretch.
CAMP4 THERAPEUTICS CORPORATION's 2040 outlook centres on $6.30, within a $3.37 to $12.13 range. That is -2% versus the projected 2035 average. That marks a +82% change versus current levels. Momentum favours further upside here.
By 2050, CAMP could reach as high as $30.08, with a base case around $13.94 and support toward $6.28 — roughly +304% from $3.45. Buyers look set to stay in control over this stretch.
Investing $1,000 in CAMP today (≈ 289.855072 CAMP) could be worth
$4,041.89
+$3,041.89 (+304%) by 2050 · US Dollar
Based on the average projected CAMP price of $13.94 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CAMPwould be worth at today's price.
$1,000 invested in CAMP on Jul 31, 2025 (≈ 613.496934 CAMP) would be worth
$2,116.56
+$1,116.56 (+111.7%) today · 2.12× · US Dollar
Based on a CAMP entry price of $1.63 vs. today's $3.45.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.16 | $1,091.77 | +9.2% |
| 1 month ago | $4.34 | $794.93 | -20.5% |
| 3 months ago | $4.05 | $851.85 | -14.8% |
| 6 months ago | $3.78 | $912.7 | -8.7% |
| 1 year ago | $1.63 | $2,116.56 | +111.7% |
| All time (1.8y) ago | $10.72 | $321.83 | -67.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CAMP forecast.
Our base-case forecast reaches $6.90 around 2050.
Implied market cap at $6.90: $358.29M
The multi-year forecast shows modest upside early on, with a transition to stronger gains in the longer term. In 2026 the average price is $3.42 with no reported ROI, reflecting a Neutral sentiment.
By 2027 the average grows to $3.57 and the max to $5.15, with a 4.4% ROI and Neutral sentiment. The 2028 forecast has an average of $3.96 and a max of $6.05, with an 15.8% ROI and Neutral sentiment.
In 2029 the average is $4.58 (min $3.11, max $7.30) with a 33.8% ROI and a Bullish sentiment. The 2030 forecast shows an average of $5.12 (min $3.34, max $8.48) with a 49.7% ROI and Bullish sentiment. The 2031–2034 windows remain Bullish with 2031 at $4.77 avg and 2032 at $4.49 avg, while ROI ranges from 39.5% to 30%.
By 2035 the average price is projected at $6.08 with a max of $11.45 and a 77.7% ROI, still Bullish. The 2040 forecast shows an average of $5.59, a max of $11.48 and a 63.3% ROI, with Bullish sentiment. The long-run view to 2050 is highly bullish, with an average price of $13.06, a max of $30.03 and a 281.8% ROI.
The figures illustrate a path to meaningful upside over the long horizon, but they are estimates and carry inherent uncertainty. Investors should consider the year-by-year ranges and sentiment shifts when evaluating risk and timing.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $3.34, an avg of $5.12, and a max of $8.48, with a ROI of 49.7% and a Bullish sentiment.
Forecasts show Neutral in earlier years and Bullish in later years, with 2030 avg $5.12 and 2050 avg $13.06 and ROI 281.8. These are estimates and not guarantees.
Yes. The forecast maximum reaches $11.45 in 2035 and $11.48 in 2040, and the 2050 max is $30.03, indicating potential to exceed $10 in the forecast horizon.
Bearish sentiment with RSI 40. The SMA50 is $4.14 and the SMA200 is $4.42. Support is $3.01 and resistance is $4.50. The 30-day range is $2.52–$4.64, with annualized volatility 90.
Current price is $3.42 and market cap is $177.59M. The rank is 3720.
CAMP4 THERAPEUTICS CORPORATION Community Discussion
0Share your CAMP4 THERAPEUTICS CORPORATION price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.